Livzon Pharmaceutical details share repurchases across several trading days

Livzon Pharmaceutical Group has released its next day disclosure report detailing significant share repurchase activities. On November 5, 2025, the company repurchased 164,200 A shares through other securities exchanges, specifically the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from RMB 36.41 to RMB 36.64 per share, totaling RMB 5,999,139.7. This brings the cumulative total of repurchased shares for the day to 164,200, all of which are intended for cancellation.

The report also details numerous other A share repurchases from December 25, 2024, through November 5, 2025. These transactions involved varying quantities of shares at different prices, with some individual repurchase amounts exceeding 500,000 shares on specific days in January and February 2025. For instance, on January 14, 2025, the company repurchased 561,400 A shares at RMB 35.62, and on February 12, 2025, 558,400 A shares were bought at RMB 35.82.

The repurchases demonstrate a consistent effort by Livzon Pharmaceutical Group to manage its share capital through the buyback program. As of November 5, 2025, the total issued H shares remain at 299,807,117, with no changes in ordinary H shares during the reported period.